US Patent Issued to Orionis Biosciences, Orionis Biosciences on March 24 for "Fibroblast activation protein binding agents and use thereof" (Belgian, American Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,583,941, issued on March 24, was assigned to Orionis Biosciences Inc. (Waltham, Mass.) and Orionis Biosciences BV (Zwijnaarde, Belgium).

"Fibroblast activation protein binding agents and use thereof" was invented by Nikolai Kley (Waltham, Mass.), Erik Depla (Zwijnaarde, Belgium) and Lennart Zabeau (Zwijnaarde, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates, in part, to agents, chimeric proteins and protein complexes that bind fibroblast activation protein (FAP) and their use as diagnostic and therapeutic agents. The present invention further relates to pharmaceutical compositions comprising the FAP binding agents, ...